Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,022 public trials 170 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

NCT00743353

Conditions: Astrocytoma, Breast Cancer, Breast Diseases, +29 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Use of 852A in Metastatic Cutaneous Melanoma.

NCT00189332

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Hôpital Hotel Dieu, 1, Pace de l' Hôpital, Lyon, France

Hôpital Ste Marguerite,Service de Dermatologie Marseille, France

Hautklinik, Medizinische Einrichtungen der Heinrich-Heine - Universität Düsseldorf Düsseldorf, Germany

Klinik und Poliklinik für Dermatologie und Venerologie Universitätsklinikum Essen Essen, Germany

View Trial Details

Completed

Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions

NCT00091689

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

NCT00099970

Conditions: Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations: University of Alabama at Birmingham-Comprehensive Cancer Ctr. Birmingham, Alabama, United States

Arizona Cancer Center Tucson, Arizona, United States

UCLA School of Medicine Los Angeles, California, United States

Cancer Institute Medical Group, Inc. Santa Monica, California, United States

View Trial Details

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

NCT00001705

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

NCT00001296

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

NCT00001577

Conditions: Body Temperature Changes, Heat Stress Disorders, Hyperthermia, +17 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

NCT00001683

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +33 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

NCT00001439

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

NCT00001685

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details